Prevalence and clinical features of bone morphogenetic protein receptor type 2 mutation in Korean idiopathic pulmonary arterial hypertension patients: The PILGRIM explorative cohort
Jang AY, Kim B-G, Kwon S, Seo J, Kim HK, Chang H-J,
PLoS ONE, 2020
12
Femoral neuropathy following venoarterial-extracorporeal membrane oxygenation therapy: a case report
Jang AY, Lim OK, Suh SY
BMC Cardiovasc Disord, 2020
13
Lipoprotein(a) and Cardiovascular Diseases ― Revisited ―
Jang AY, Han SH, Sohn IS, Oh PC, Koh KK
Circ J, 2020
14
Design and rationale of a randomized control trial testing the effectiveness of combined therapy with STAtin plus FENOfibrate and statin alone in non-diabetic, combined dyslipidemia patients with non-intervened intermediate coronary artery disease - STAFENO study
Kwon T-G, Jang AY, Kim SW, Hong YJ, Bae J-H, Lee SY, Kim S-H, Han SH
Trials, 2020
15
STAtin plus FENOfibrate and statin alone in non-diabetic, combined dyslipidemia patients with non-intervened intermediate coronary artery disease - STAFENO study
Co-First author, unknown
Trials, 2020
16
Feasibility and Applicability of Wireless Handheld Ultrasound Measurement of Carotid Intima-Media Thickness in Patients with Cardiac Symptoms
Jang AY, Ryu J, Oh PC, Moon J, Chung WJ
Yonsei Med J, 2020
17
Echocardiographic Screening Methods for Pulmonary Hypertension: A Practical Review
Jang AY, Shin MS
J Cardiovasc Imaging, 2020
18
Current status of pulmonary arterial hypertension in Korea
Jang AY, Chung WJ
Korean J Intern Med, 2019
19
A Nationwide multicenter registry and biobank program for deep phenotyping of idiopathic and hereditary pulmonary arterial hypertension in Korea: the PAH platform for deep phenotyping in Korean subjects (PHOENIKS) cohort
Jang AY, Kim S, Park SJ, Choi H, Oh PC, Oh S, Kim KH, Kim KH, Byun K, Chung WJ, Investigators P
Clin Hypertens, 2019
20
Cardiac Structural or Functional Changes Associated with CHA2DS2-VASc Scores in Nonvalvular Atrial Fibrillation: A Cross-Sectional Study Using Echocardiography